The government is planning to establish a 2,000-acre pharmaceutical innovation park in the Osudoku area as part of efforts to reduce the country's dependence on imported medicines and strengthen local pharmaceutical manufacturing. This ambitious project, dubbed the Legon Pharmaceutical Innovation Park, aims to create an integrated ecosystem covering pharmaceutical manufacturing, medical-device production, herbal medicine, and research and development.
Land Acquisition and Community Engagement
The 24-Hour Economy Authority, the body overseeing the project, is engaging traditional authorities and communities through a participatory land acquisition model. This approach ensures that landowners and communities not only receive rental income but also have the opportunity to become shareholders in the park. As Head of Technical Delivery and Design at the 24-Hour Economy Authority, Kafui Linda Abbah Foli, explained, "Aside from paying them their rental income, they will be shareholders in the park. So every year they get some dividends and also get some rental income."
Infrastructure and Job Creation
The park will provide essential infrastructure, including roads, water, electricity, wastewater treatment, and specialised pharmaceutical effluent treatment facilities. This integrated ecosystem is expected to create up to 20,000 jobs within the first five years of the park's development. According to Ms. Abbah Foli, the project aims to address the major challenges facing pharmaceutical manufacturers, particularly access to land and critical infrastructure.
Reducing Dependence on Imported Medicines
Ghana currently imports about 70% of its pharmaceutical needs, including finished medicines, active pharmaceutical ingredients (APIs), and excipients such as starch and alcohol. The Legon Pharmaceutical Innovation Park is designed to cover the pharmaceutical value chain and reduce the country's vulnerability to disruptions in global supply chains. Ms. Abbah Foli emphasized the need for self-sufficiency, saying, "The goal is to ensure that we build a park that will cater for the whole value chain so that when we are confronted by a pandemic like COVID in the future, we will be self-sufficient."
Attracting Investors and Manufacturers
The Authority has identified potential tenants, including existing pharmaceutical manufacturers in Ghana and international companies from India, China, and the United States. Ghanaian health professionals living abroad have also expressed interest in the project. Ms. Abbah Foli said the country is drawing lessons from pharmaceutical parks in India and seeking to attract some companies operating within those ecosystems to establish operations in the country.
Strengthening Domestic Pharmaceutical Industry
The Legon Pharmaceutical Innovation Park is part of a broader ambition to build a stronger domestic pharmaceutical industry capable of meeting a greater share of Ghana's medicine needs while creating jobs and attracting investment. The project aims to support local production of medical devices, including HIV and malaria test kits, which are currently largely imported. As Ms. Abbah Foli noted, "The Authority believes expanding domestic manufacturing capacity will improve Ghana's preparedness for future health emergencies."
Conclusion
The establishment of the Legon Pharmaceutical Innovation Park is a significant step towards reducing Ghana's dependence on imported medicines and strengthening its local pharmaceutical manufacturing capacity. With a focus on integrated infrastructure, job creation, and community engagement, this ambitious project has the potential to transform the country's pharmaceutical sector and improve access to essential medicines for its citizens. As the project moves forward, it remains to be seen how the government and the 24-Hour Economy Authority will navigate the complex challenges and opportunities that lie ahead.
Source: Joy Online
